Late cardiopulmonary morbidity in patients with Hodgkin lymphoma: a retrospective nationwide registry study
Annals of Hematology · 22.07.2026 · 105 (11)
DOI: 10.1007/s00277-026-07193-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Hematology, online erschienen am 22.07.2026. Verfasst von Noora Hannuksela und 12 weiteren Autor:innen. Beteiligte Einrichtung: Oncology, Faculty of Health Medicine, School of Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland. nhannuks@st…. Hauptthemen laut MEDLINE: Hodgkin Disease, Registries, Heart Failure. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Eastern Finland.
Abstract (Originalsprache)
Hodgkin lymphoma (HL) is a B-cell neoplasm with a cure rate of 90%. Previous data on late morbidity in patients with HL cover the era of older treatment modalities. This real-world study consisted of 2912 patients diagnosed with HL between 2000 and 2019 in Finland and aimed to clarify the incidence of late-onset cardiopulmonary morbidity compared to matched controls. Patient data were collected from four nationwide Finnish healthcare registries. We reported a higher occurrence of coronary artery disease in patients aged < 50 years at diagnosis than in controls (RR 3.80 (2.16–6.74), p < 0001). Additionally, a higher incidence of both heart failure (RR 1.68 (1.28–2.21), p < 0.001) and valvular heart disease (RR 1.80 (1.17–2.78), p = 0.006) was detected in patients aged ≥ 50 years at diagnosis than in the controls. Remarkably, in the < 50 years age group, the incidences of pneumonia (RR 4.89 (3.58–6.71), p < 0.001) and pulmonary embolism (RR 7.78 (2.75–21.95), p < 0.001) were higher than those in the control group. In conclusion, with the current treatment modalities, late cardiopulmonary morbidity in long-term survivors remains a great challenge. A strategy for primary prevention and early detection of late toxicity remains crucial and a critical evaluation of current treatment practices is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Oncology, Faculty of Health Medicine, School of Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland. nhannuks@student.uef.fi.
- Oncology, Faculty of Health Medicine, School of Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
- Department of Oncology, Kuopio University Hospital, Kuopio, Finland.
- Medaffcon Oy, Espoo, Finland.
- Department of Oncology, Department of Radiotherapy, Kuopio University Hospital, Kuopio, Finland.
- Cancer Centre, Oulu University Hospital, Oulu, Finland.
Förderung
- University of Eastern Finland
Zitieren
APA
Hannuksela, N., Kuittinen, O., Rönkä, A., Anttalainen, A., Ukkola-Vuoti, L., Toppila, I., Vikkula, J., Seppälä, J., Vuolukka, K., Marin, K., Kuitunen, H., Miettinen, T., & Partanen, A. (2026). Late cardiopulmonary morbidity in patients with Hodgkin lymphoma: a retrospective nationwide registry study. Annals of Hematology, 105(11). https://doi.org/10.1007/s00277-026-07193-9
Vancouver
Hannuksela N, Kuittinen O, Rönkä A, Anttalainen A, Ukkola-Vuoti L, Toppila I, et al. Late cardiopulmonary morbidity in patients with Hodgkin lymphoma: a retrospective nationwide registry study. Annals of Hematology. 2026;105(11). doi:10.1007/s00277-026-07193-9
BibTeX
@article{Hannuksela2026,
author = {Hannuksela, Noora and Kuittinen, Outi and Rönkä, Aino and Anttalainen, Anna and Ukkola-Vuoti, Liisa and Toppila, Iiro and Vikkula, Johanna and Seppälä, Jan and Vuolukka, Kristiina and Marin, Katja and Kuitunen, Hanne and Miettinen, Tatu and Partanen, Anu},
title = {Late cardiopulmonary morbidity in patients with Hodgkin lymphoma: a retrospective nationwide registry study},
journal = {Annals of Hematology},
year = {2026},
volume = {105},
number = {11},
doi = {10.1007/s00277-026-07193-9}
}
EUVIMED